$9.300
+0.020 (+0.22%)終値時点
価格予想
アプリで開くと、より長期の予想を確認できます。
類似チャート分析による RNAC の予測・予想
Alphio's RNAC stock price prediction model matches the current Cartesian Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $9.11 (-2.01%). The 1-week path is $9.12 (-1.93%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Cartesian Therapeutics Inc 株は買うべき？
Cartesian Therapeutics Inc is a good buy right now due to its recent strategic licensing deal that has driven the stock up over 30%, indicating strong market confidence. The current price is $9.60, which is significantly lower than the analyst price target of $25, suggesting substantial upside potential. Additionally, the company has a gross margin of 100%, showing strong profitability potential on revenues. However, a key risk is the forward P/E ratio of 25.06, indicating that the stock may be overvalued relative to its earnings potential in the near term.
RNAC の株価は Tuesday に $9.30 で引け、その前に上昇 +0.22%
Cartesian Therapeutics Inc (RNAC) last closed at $9.3, gaining +0.22%. These facts feed the 1-day and 1-week RNAC price prediction above.
予想の要因
Cartesian Therapeutics Inc（RNAC）の予想は、類似したチャートパターン・季節性・移動平均を組み合わせています。
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bullish
類似チャートパターン
直近の値動きが RNAC に最も近い銘柄を、類似度順に表示します。
RNAC の季節性分析
Historically the probability of a positive September return for RNAC is 2.38%. January offers the highest probability of a positive month at 85.25%, while September is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
本ページは調査目的であり、投資助言ではありません。モデルは誤ることがあります。過去の実績は将来の成果を保証しません。